3309 — C-Mer Medical Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual income statement for C-Mer Medical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,113	1,732	1,924	1,913	1,947
Cost of Revenue
Gross Profit	358	448	619	597	604
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,088	1,768	1,805	1,979	1,779
Operating Profit	24.7	-36.5	119	-66.2	167
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26.9	-11.2	124	-76.2	156
Provision for Income Taxes
Net Income After Taxes	16.2	-46.2	86.3	-108	111
Minority Interest
Net Income Before Extraordinary Items
Net Income	21.9	-21.9	62	-135	100
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	21.9	-21.9	62	-135	100
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.021	-0.018	0.052	-0.005	0.071
Dividends per Share
Special Dividends per Share